United States
Include All CSL Behring Country Sites

ZLB Behring Introduces the Mix2Vial™ Alternate Transfer Device

New Way to Reconstitute Products Answers Patients' Call for Simplicity and Ease of Use

King of Prussia, PA — 25 July 2005

ZLB Behring announced today the availability of the Mix2Vial Alternate Transfer Device, a new way to reconstitute products in 20/20 mm vials. The Mix2Vial is a plastic, needle-less device with a built-in filter, no handle to manipulate, and no glass syringes. Designed in answer to requests from patients and their families for a device that is simpler to use than anything else already on the market, the Mix2Vial is user-friendly. Among other things, it features color-coded ends that visually distinguish the sterile water vial from the product vial. For nurses, pharmacists, patients, and others mixing products, the Mix2Vial is an efficient, convenient and easy-to-use alternative to existing transfer devices.

In test groups, patients and parents preferred the new transfer device compared to other currently available reconstitution devices. “Hundreds of consumers have had the opportunity to see the Mix2Vial in action and the response has been that the Mix2Vial is easy to use. This is a clear demonstration of ZLB Behring’s commitment to innovation with the goal of bringing greater quality of life to patients who use our products,” said Paul Perreault, U.S. Vice President and General Manager of Commercial Operations at ZLB Behring.

ZLB Behring has set up a Web site for those who wish to see the Mix2Vial in action online. The site, www.zlbbehringmix2vial.com, provides a step-by-step demonstration of reconstituting products with the Mix2Vial Alternate Transfer Device.

Patients and their families can also arrange to see the Mix2Vial in person by contacting their healthcare professional, by calling ZLB Behring Medical Information at 1-800-504-5434 or by contacting their local ZLB Behring representative to learn where they can attend one of the demonstrations being held at events scheduled across the United States.

For healthcare professionals, ZLB Behring is offering a compact training kit that includes everything needed to learn to use the Mix2Vial and demonstrate it to patients and their families. To reinforce the demonstration, a handy take-home kit is available for patients.

About ZLB Behring

ZLB Behring is a global leader in the plasma protein biotherapeutics industry. Dedicated to improving the quality of life for patients throughout the world, ZLB Behring provides safe and effective plasma-derived and recombinant products and offers patients a wide range of related services. The company’s broad portfolio of life-saving therapeutics is used in the treatment of individuals with hemophilia and other bleeding disorders, immune deficiency disorders and inherited emphysema; the prevention of hemolytic diseases for the newborn; cardiac surgery patients; and shock and burn victims. Additionally, ZLB Behring operates one of the world’s largest, fully-owned plasma collection networks. ZLB Behring is a subsidiary of CSL Limited, a bio-pharmaceutical company, which operates worldwide from its headquarters in Melbourne, Australia. For more information, please visit www.ZLBBehring.com.
CRP16-05-0001 05/2016
© 2017 CSL Behring